Baricitinib

baricitinib · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

108 regulatory and trial events tracked for Baricitinib, covering 2017-04-21 to 2026-08-11. Get the full timeline:

Most recent: Clinical Trial Results: A Study of Baricitinib (LY3009104) in Children With COVID-19 [Phase 3]